Alle Fotos(1)

Key Documents

Ursprungszeugnis (CoO)/Analysenzertifikate (CoA)

A172

1-Aminocyclobutane-cis-1,3-dicarboxylic acid

Name: 1-Aminocyclobutane-<I>cis</I>-1,3-dicarboxylic acid
Brand: SIGMA

Synonym(e):

1-Amino-cis-1,3-cyclobutanedicarboxylic acid, cis-ACDA

Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise

Alle Fotos(1)

About This Item

UNSPSC-Code:

12352200

Löslichkeit

0.1 M NaOH: 12 mg/mL
0.1 M HCl: 14 mg/mL
H₂O: 5.2 mg/mL
methanol: insoluble

Biochem./physiol. Wirkung

Potent and selective NMDA receptor agonist

Sonstige Hinweise

Note: Under IUPAC nomenclature, this compound is designated as trans

Piktogramme

GHS07

Signalwort

Warning

H-Sätze

H315,H319,H335

P-Sätze

P261 - P305 + P351 + P338

Gefahreneinstufungen

Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

Lagerklassenschlüssel

11 - Combustible Solids

WGK

WGK 3

Flammpunkt (°F)

Not applicable

Flammpunkt (°C)

Not applicable

Persönliche Schutzausrüstung

dust mask type N95 (US), Eyeshields, Gloves

Analysenzertifikate (COA)

Suchen Sie nach Analysenzertifikate (COA), indem Sie die Lot-/Chargennummer des Produkts eingeben. Lot- und Chargennummern sind auf dem Produktetikett hinter den Wörtern ‘Lot’ oder ‘Batch’ (Lot oder Charge) zu finden.

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

Synthesis and activity of a potent N-methyl-D-aspartic acid agonist, trans-1-aminocyclobutane-1,3-dicarboxylic acid, and related phosphonic and carboxylic acids.

R D Allan et al.

Journal of medicinal chemistry, 33(10), 2905-2915 (1990-10-01)

We report the synthesis of a series of 3-carboxy-, 3-(carboxymethyl)-, 3-(omega-phosphonoalkyl)-1-aminocyclobutane-1-carboxylic acids for evaluation as agonists or antagonists of neurotransmission at excitatory amino acid receptors, particularly N-methyl-D-aspartic acid (NMDA) receptors. The compounds were evaluated as agonists on their ability to

The histone demethylase KDM5A is a key factor for the resistance to temozolomide in glioblastoma.

Barbara Banelli et al.

Cell cycle (Georgetown, Tex.), 14(21), 3418-3429 (2015-11-15)

Notwithstanding current multimodal treatment, including surgery, radiotherapy and chemotherapy with temozolomide (TMZ), median survival of glioblastoma (GBM) patients is about 14 months, due to the rapid emergence of cell clones resistant to treatment. Therefore, understanding the mechanisms underlying chemoresistance is

Lentivirus-mediated silencing of spindle and kinetochore-associated protein 1 inhibits the proliferation and invasion of neuronal glioblastoma cells.

Xiujuan Shi et al.

Molecular medicine reports, 11(5), 3533-3538 (2015-01-13)

Spindle and kinetochore‑associated protein 1 (SKA1) is an important component of the human kinetochore, which plays a key role in mitosis. The resent study was designed to investigate the role of SKA1 in human glioblastoma. The results of the present

Glycogen synthase kinase 3β sustains invasion of glioblastoma via the focal adhesion kinase, Rac1, and c-Jun N-terminal kinase-mediated pathway.

Yuri Chikano et al.

Molecular cancer therapeutics, 14(2), 564-574 (2014-12-17)

The failure of current treatment options for glioblastoma stems from their inability to control tumor cell proliferation and invasion. Biologically targeted therapies offer great hope and one promising target is glycogen synthase kinase-3β (GSK3β), implicated in various diseases, including cancer.

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung.